Medicover AB (publ) (MCOV_B) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

The MediCover Q1 2025 report presentation. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, CEO Frederick Rugemark and CFO Anand Patel. Please go ahead. Good morning everyone and welcome to the first quarter 2025 results presentation. It's with great pride and joy we present this report. In fact, I think it's probably the best report we have presented. possibly with the exception of one or two covid doped pandemic reports but in terms of the broad business it is definitely the best report we have published since we listed the company now eight years ago it's a combination of factors you know we see continued strong top line growth organic growth was more than 14 percent most importantly The further down the profit and loss statement you see, the more operational leverage you see coming down in margins expanding. EBITDA margin up 1.6 percentage points, EBIT margin up 2.4 percentage points, and it goes on as you flow through down the profit and loss statement, which is exactly what we have been focused on. It is exactly what we have been reporting to you over the past four or five quarters. It is just that as the numbers get bigger, it becomes a bit more pronounced. And that's really what we see here. Poland continues for healthcare services to be really very strong. Now, India had a particularly weak quarter. and we'll speak a little bit more about that later on but I think it's noteworthy to see that we push through these results both growth and margin expansion despite actually you can argue a disappointing a quarter out of one of our core market...